Caas Capital Management LP Molecular Partners Ag Transaction History

Caas Capital Management LP

  • $552 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$9.99 - $20.49 $230,479 - $472,724
-23,071 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$18.34 - $21.0 $677,277 - $775,509
-36,929 Reduced 61.55%
23,071 $452,000
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.01 $1.16 Million - $1.26 Million
60,000 New
60,000 $1.23 Million

Others Institutions Holding MOLN

# of Institutions
6
Shares Held
849K
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $166M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email